Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lifecare AS ( (DE:LFC0) ) has provided an update.
Lifecare ASA announced the exercise period for its 4,193,806 warrants, which allows holders to subscribe for new shares at a specified price, will conclude today. Warrants not exercised by the deadline will become worthless, potentially diluting the shareholding of those who do not act. This development is part of a rights issue completed in June 2024, and it may impact stakeholders by altering the company’s share distribution and financial structure.
More about Lifecare AS
Lifecare ASA is a medical sensor company that focuses on developing technology for the sensing and monitoring of various body analytes. The company aims to bring the next generation of Continuous Glucose Monitoring (CGM) systems to market, utilizing osmotic pressure as a sensing principle. Their sensor technology is designed to identify and monitor a wide range of analytes and molecules in both humans and pets.
Average Trading Volume: 40,922
Current Market Cap: NOK106.5M
See more data about LFC0 stock on TipRanks’ Stock Analysis page.